Abstract
Cancer-associated fibroblasts (CAFs) significantly influence biological properties of many tumors. The role of these mesenchymal cells is also anticipated in human gliomas. To evaluate the putative role of CAFs in glioblastoma, we tested the effect of CAF conditioned media on the proliferation and chemotaxis of glioma cells. The proliferation of glioma cells was stimulated to similar extent by both the normal fibroblasts (NFs) and CAF-conditioned media. Nevertheless, CAF-conditioned media enhanced the chemotactic migration of glioma cells significantly more potently than the media from normal fibroblasts. In order to determine whether CAF-like cells are present in human glioblastomas, immunofluorescence staining was performed on tissue samples from 20 patients using markers typical for CAFs. This analysis revealed regular presence of mesenchymal cells expressing characteristic CAF markers α-smooth muscle actin and TE-7 in human glioblastomas. These observations indicate the potential role of CAF-like cells in glioblastoma biology.
Similar content being viewed by others
References
Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends in genetics. TIG. 2009;25(1):30–8. doi:10.1016/j.tig.2008.10.012.
Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res. 2011;1(4):482–97.
Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem Off J Histochem Soc. 2008;56(4):347–58. doi:10.1369/jhc.7A7287.2007.
Smetana K, Dvorankova B, Szabo P, Strnad H, Kolar M. Role of stromal fibroblasts in cancer originated from squamous epithelia. In: Bai X, editor. Dermal fibroblasts: histological perspectives, characterization and role in disease. New York: Nova Sciences Publishers; 2013. p. 83–94.
De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer J Int du Cancer. 2008;123(10):2229–38. doi:10.1002/ijc.23925.
Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle. 2009;8(4):589–95.
Strnad H, Lacina L, Kolar M, Cada Z, Vlcek C, Dvorankova B, et al. Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol. 2010;133(2):201–11. doi:10.1007/s00418-009-0661-6.
Kolar M, Szabo P, Dvorankova B, Lacina L, Gabius HJ, Strnad H, et al. Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: immunohistochemical and transcriptomic analyses. Biol Cell / Under Auspices Europ Cell Biol Org. 2012;104(12):738–51. doi:10.1111/boc.201200018.
Dvorankova B, Szabo P, Lacina L, Gal P, Uhrova J, Zima T, et al. Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair. Cells Tissues Organs. 2011;194(6):469–80. doi:10.1159/000324864.
Valach J, Fik Z, Strnad H, Chovanec M, Plzak J, Cada Z, et al. Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors. Int J Cancer J Int du Cancer. 2012;131(11):2499–508. doi:10.1002/ijc.27550.
Mifkova A, Kodet O, Szabo P, Kucera J, Dvorankova B, Andre S, et al. Synthetic polyamine BPA-C8 inhibits TGF-beta1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro. Chembiochem Europ J Chem Biol. 2014;15(10):1465–70. doi:10.1002/cbic.201402087.
Dvorankova B, Szabo P, Lacina L, Kodet O, Matouskova E, Smetana Jr K. Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line. Histochem Cell Biol. 2012;137(5):679–85. doi:10.1007/s00418-012-0918-3.
da Fonseca AC, Badie B. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clinic Dev Immunol. 2013;2013:264124. doi:10.1155/2013/264124.
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 2012;60(3):502–14.
Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, et al. Isolation of a new cell population in the glioblastoma microenvironment. J Neuro-Oncol. 2012;106(3):493–504. doi:10.1007/s11060-011-0701-7.
Clavreul A, Guette C, Faguer R, Tetaud C, Boissard A, Lemaire L, et al. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. J Pathol. 2014;233(1):74–88. doi:10.1002/path.4332.
Busek P, Stremenova J, Sromova L, Hilser M, Balaziova E, Kosek D, et al. Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. Int J Biochem Cell Biol. 2012;44(5):738–47. doi:10.1016/j.biocel.2012.01.011.
Haynes BF, Scearce RM, Lobach DF, Hensley LL. Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Experiment Med. 1984;159(4):1149–68.
Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem. 2007;101(4):805–15. doi:10.1002/jcb.21159.
Filatova A, Acker T, Garvalov BK. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta. 2013;1830(2):2496–508. doi:10.1016/j.bbagen.2012.10.008.
Persano L, Rampazzo E, Basso G, Viola G. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. Biochem Pharmacol. 2013;85(5):612–22. doi:10.1016/j.bcp.2012.10.001.
Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A pericyte origin of spinal cord scar tissue. Science. 2011;333(6039):238–42. doi:10.1126/science.1203165.
Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol. 1995;54(3):304–10.
Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, Myers SM, et al. Cellular host responses to gliomas. PLoS One. 2012;7(4):e35150. doi:10.1371/journal.pone.0035150.
Behnan J, Isakson P, Joel M, Cilio C, Langmoen IA, Vik-Mo EO, et al. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells. 2014;32(5):1110–23. doi:10.1002/stem.1614.
Birnbaum T, Hildebrandt J, Nuebling G, Sostak P, Straube A. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro. J Neuro-Oncol. 2011;105(1):57–65. doi:10.1007/s11060-011-0561-1.
Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A. 1991;88(14):6028–32.
Prowse AB, McQuade LR, Bryant KJ, Marcal H, Gray PP. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res. 2007;6(9):3796–807. doi:10.1021/pr0702262.
Sayegh ET, Kaur G, Bloch O, Parsa AT. Systematic review of protein biomarkers of invasive behavior in glioblastoma. Mol Neurobiol. 2014;49(3):1212–44. doi:10.1007/s12035-013-8593-5.
Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, et al. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol. 2002;61(7):585–96.
Acknowledgments
This work was supported by the following grants: Grant Agency of the Charles University in Prague (GAUK) project 44214, Internal Grant Agency of the Ministry of Health of the Czech Republic (IGA) project 12237-5/2011, University Research Centers (UNCE) project 204013, Charles University Research Development Schemes (PRVOUK) project P27/LF1/1, Czech Science Foundation (GAČR) project P304-12-1333, Specific Academic Research Projects (SVV) project 260032, and by the project “BIOCEV – Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University” (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund.
Ethical approval
An informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trylcova, J., Busek, P., Smetana, K. et al. Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro. Tumor Biol. 36, 5873–5879 (2015). https://doi.org/10.1007/s13277-015-3259-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-3259-8